Table 2 3-year survival outcomes for patients received different treatment model.

From: Induction chemotherapy followed by concurrent chemoradiotherapy is benefit for advanced stage nasopharyngeal carcinoma with different nonkeratinizing carcinoma subtypes

 

Before match

P value

After match

P value

IC + CCRT

CCRT

IC + CCRT

CCRT

LRFS

96.6%

90.1%

<0.001

96.9%

100%

0.65

PFS

80.7%

62%

<0.001

78.1%

56%

<0.001

DMFS

81%

71.1%

0.056

82%

66.5%

0.045

OS

84.7%

75.6%

0.007

83.8%

72.7%

0.011

  1. IC + CCRT, induction chemotherapy plus concurrent chemoradiotherapy; CCRT, concurrent chemoradiotherapy; LCFS, local recurrence-free survival; PFS, progression free survival; DMFS, distant metastasis-free survival; OS, overall survival.
Back to article page